Healthcare IT News January 18, 2022
Tammy Lovell

The firms’ early warning system aims to increase pandemic preparedness.

German biotech firm BioNTech and UK-based artificial intelligence (AI) specialists InstaDeep have partnered to develop an early warning system (EWS) for dangerous new COVID-19 variants.

The new computational method combines structural modelling of the viral Spike protein and AI algorithms to flag potential high-risk variants (HRVs) entered into SARS-CoV-2 sequence data repositories within less than a day.

It combines metrics, based on a variant’s fitness and immune escape properties, into a score indicating its risk of impacting global health.

During a trial period, the EWS identified more than 90% of variants designated by the World Health Organisation (WHO) as potentially dangerous, on average two months in advance – including Alpha,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Partnerships, Patient / Consumer, Pharma / Biotech, Provider, Public Health / COVID, Trends
STAT+: After gene therapy, two congenitally deaf children hear for the first time
Pharma has over $500B in capital for deals
Could this genetic variant cause some Alzheimer's cases? What a new study suggests.
mRNA vaccines helped us fight COVID-19. Could cancer be next?
STAT+: Pharmalittle: We’re reading about a boy dying in Pfizer trial; AstraZeneca yanking Covid shot, and more

Share This Article